SEC Form 4 · accession 0001127602-17-032439

HAEMONETICS CORP · HAE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Chief Financial Officer

Period of report

Nov 14, 2017

Accepted (ET)

Nov 16, 2017 · 5:34 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000313143

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Nov 14, 2017	M	11,231	$34.21	A	27,227	D
Common Stock	Nov 14, 2017	S	9,909	$54.00	D	17,318	D
Common Stock	Nov 14, 2017	S	1,122	$54.01	D	16,196	D
Common Stock	Nov 14, 2017	S	100	$54.03	D	16,096	D
Common Stock	Nov 14, 2017	S	100	$54.04	D	15,996	D
Common Stock	Nov 14, 2017	S	200	$54.10	D	15,796	D
Common Stock	Nov 14, 2017	S	200	$54.29	D	15,596	D
Common Stock	Nov 14, 2017	S	200	$54.15	D	15,396	D
Common Stock	Nov 14, 2017	S	100	$54.16	D	15,296	D
Common Stock	Nov 14, 2017	S	100	$54.17	D	15,196	D
Common Stock	Nov 14, 2017	S	100	$54.19	D	15,096	D
Common Stock	Nov 14, 2017	S	39	$54.20	D	15,057	D
Common Stock	Nov 14, 2017	S	161	$54.21	D	14,896	D
Common Stock	Nov 14, 2017	S	100	$54.233	D	14,796	D
Common Stock	Nov 14, 2017	S	100	$54.28	D	14,696	D
Common Stock	Nov 14, 2017	S	200	$54.29	D	14,496	D
Common Stock	Nov 14, 2017	S	200	$54.31	D	14,296	D
Common Stock	Nov 14, 2017	S	100	$54.33	D	14,196	D
Common Stock	Nov 14, 2017	S	162	$54.34	D	14,034	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-qualified Stock Option (Right to Buy)	$34.21	Nov 14, 2017	M	11,231	D	Oct 25, 2017	Oct 25, 2023	Common Stock	11,231	33,695	D